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Event-related-potentialsDehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEAS)may havemood enhancement ef-
fects: higher DHEAS concentrations and DHEA/cortisol ratio have been related to lower depression scores and con-
trolled trials of DHEA administration have reported signiﬁcant antidepressant effects. The balance between DHEAS
and DHEA has been suggested to inﬂuence brain functioning. We explored DHEAS, DHEA, cortisol, DHEA/cortisol
and DHEAS/DHEA ratios relations to the processing of negative emotional stimuli at behavioral and brain levels
by recording the electroencephalogram of 21 young women while performing a visual task with implicit neutral
or negative emotional content in an audio–visual oddball paradigm. For each condition, salivary DHEA, DHEAS
and cortisol were measured before performing the task and at 30 and 60 min intervals. DHEA increased after task
performance, independent of the implicit emotional content. With implicit negative emotion, higher DHEAS/
DHEA and DHEA/cortisol ratios before task performance were related to shorter visual P300 latencies suggesting
faster brain processing under a negative emotional context. In addition, higher DHEAS/DHEA ratios were related
to reduced visual P300 amplitudes, indicating less processing of the negative emotional stimuli. With this study,
we could show that at the electrophysiological level, higher DHEAS/DHEA and DHEA/cortisol ratios were related
to shorter stimulus evaluation times suggesting less interference of the implicit negative content of the stimuli
with the task. Furthermore, higher DHEAS/DHEA ratios were related to reduced processing of negative emotional
stimuli which may eventually constitute a protective mechanism against negative information overload.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-
sulfate (DHEAS) are neuroactive steroids and their concentrations
in the central nervous system are higher than in the peripheral circula-
tion (Dong and Zheng, 2011; Lacroix et al., 1987). Although their phys-
iological role and mechanisms of action are still a matter of debate
(Komesaroff, 2008), a growing amount of evidence has been accumu-
lating regarding their actions in the central nervous system. Concerning
cognitive functions, higher DHEAS levels were related to improvedculdade de Medicina de Lisboa,
Av. Professor EgasMoniz, 1649-
c. This is an open access article undermemory (Barrett-Connor and Edelstein, 1994), whereas low levels
were found in Alzheimer's disease (Weill-Engerer et al., 2002). Besides,
higher DHEA, DHEAS or DHEA-to-cortisol levels were related to
improved attention (Wolf et al., 1997), lower perceived stress and
also to improved performance under stressful conditions (Morgan
et al., 2009; Russo et al., 2012).
Furthermore, higher DHEAS concentrations and DHEA-to-cortisol
ratios have been related to lower prevalence of depression, lower de-
pression ratings and higher well-being scores (Barrett-Connor and
Edelstein, 1994; Barrett-Connor et al., 1999; Michael et al., 2000;
Young et al., 2002). The relation betweenDHEA levels alone and depres-
sion is less consistent. In fact, several groups have found that DHEA-to-
cortisol ratios, rather than concentrations of either hormone alone, dis-
criminatedmore accurately depressed from non-depressed individuals,
with lower DHEA-to-cortisol ratios as seen in depression (Assies et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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patients who remained depressed after several months (Goodyer
et al., 1998).
It was hence suggested that elevated DHEA and DHEAS relative to
cortisol levels, may counteract the negative effects of high cortisol on
mood (Goodyer et al., 1998; Kaminska et al., 2000). Moreover, con-
trolled trials of DHEA therapy have reported signiﬁcant positive effects
on mood (Bloch et al., 1999; Schmidt et al., 2005; Wolkowitz et al.,
1999). These mood improvements were related to increases in the cir-
culating concentrations of DHEA andDHEAS and to increases in their ra-
tios with cortisol. On the other hand, sulfated steroids in general
possibly act as endogenous neuromodulators (Gibbs et al., 2006) and
the balance betweenDHEAS andDHEA has also been suggested to inﬂu-
ence brain functioning. In a study assessing both DHEA and DHEAS, de-
pressed patients had low DHEAS but normal DHEA concentrations
(Scott et al., 1999). In a different setting, but also pointing towards the
importance of DHEAS to DHEA balance, it has been shown that subjects
with Alzheimer's disease have increased levels of DHEA in the central
nervous system, but a reduced conversion of DHEA into DHEAS and
consequently, reduced DHEAS/DHEA ratios (Kim et al., 2003).
Glucocorticoids' effects are not always deleterious. In fact, glucocor-
ticoids have biphasic effects on fear conditioning: although mild or
short lasting increases in glucocorticoids in relation to stress may have
beneﬁcial effects on attention and promote adaptation, higher cortisol
levels or long term increases have deleterious effects on executive func-
tioning, attention, learning, memory and cognitive ﬂexibility (Campeau
et al., 2011; McEwen, 2012). Again, anti-glucocorticoid effects of DHEA
and DHEAS have been proposed in what concerns cognition and
performance.
DHEA and DHEAS present a general neurostimulatory effect, but
DHEAS has a much more potent excitatory action than DHEA (Baulieu
and Robel, 1998; Imamura and Prasad, 1998; Monnet et al., 1995; Dong
and Zheng, 2011). At the cellular level DHEAS antagonizes the neurotoxic
effect of high doses of DHEA in mouse neuronal cultures (Gil-ad et al.,
2001) and DHEA is protective against the neurotoxic effects of corticoste-
rone (Balazs et al., 2008). Hence, the simultaneous evaluation of DHEA,
DHEAS and cortisol and the ratios of DHEA-to-cortisol and DHEAS-to-
DHEA may uncover more information than the individual examination
of either steroid alone.
DHEA and DHEAS effects on cerebral regions speciﬁcally involved in
emotional processing including the amygdale, hippocampus, insula and
anterior cingulated cortex have been suggested. However, little re-
search has explored the neural correlates of DHEA and DHEAS with re-
spect to emotion and mood. In this regard, a study using LORETA
showed that DHEA administration increased the activity in the anterior
cingulate cortex (Alhaj et al., 2006). Another recent study using func-
tional Magnetic Resonance Imaging (fMRI) found that DHEA reduces
the activity in regions associated with the generation of negative emo-
tion and enhances activity in regions linked to regulatory processes
(Sripada et al., 2013).
DHEA and DHEAS relations to emotional processing at the electro-
physiological level are not known. Regarding cortisol, its administration
increased the processing of angry faces in highly anxious individuals as
indicated by increased amplitudes of early (P150) and late (P3) event-
related potentials (van Peer et al., 2007). DHEA and DHEAS may modu-
late attention, cognition and mood while their response to emotional
stimuli is mostly unexplored.
The aim of the present study was to explore whether DHEA and
DHEAS levels would have an inﬂuence on involuntary attention and
emotional stimuli processing at the performance and brain levels and,
on the other hand, if an emotional challenge would alter DHEA and
DHEAS levels. Furthermore, we wanted to examine the relation of
DHEA and DHEAS with cortisol levels. The a priori hypotheses were:
1) higher endogenous DHEAS and DHEA levels as well as higher
DHEA-to-cortisol and DHEAS-to-DHEA levels may protect from invol-
untary distraction and enhance brain processing and performanceunder a negative emotional context; 2) DHEAS and DHEA effects may
be largely antagonistic from those of baseline cortisol; 3) in the short
term, a negative emotional context might be a stimulus for DHEA and
cortisol secretion.
To test these hypotheseswe used a visual taskwith a neutral or neg-
ative emotional context and unexpected auditory novel sounds aimed
to cause distraction. In this paradigm, the negative emotional context
is expected to elicit an increased attention capture when compared to
non-emotional faces (Öhman et al., 2001) and consequently deteriorate
performance (Domínguez-Borràs et al., 2008). Furthermore, auditory
distraction by novel sounds is expected to elicit a novelty-P3 compo-
nent in the electroencephalogram (EEG) and also deteriorate perfor-
mance (Corral and Escera, 2008; Domínguez-Borràs et al., 2008;
Escera et al., 1998, 2000). We recorded performance parameters, the
EEG and took saliva samples in order to determine the hormonal levels
before and after the task. We explored DHEA, DHEAS, cortisol, DHEA/
cortisol ratio andDHEAS/DHEA ratio relations to distraction and implicit
negative emotion at the performance and electrophysiological levels.
Participants and methods
Participants
21 healthy female volunteers (university students) from 18 to
26 years (mean 21 ± 1), performed the study protocol. Only women
were included as to ensure higher homogeneity in emotional processing
(Garcia-Garcia et al., 2008) and androgen levels. All had normal or
corrected-to-normal vision and none reported auditory deﬁcits. There
was no history of neurologic, psychiatric, endocrine or oral diseases.
Subjects were asked to refrain from alcohol intake in the 12 h before
the experimental protocol and tobacco and illicit drug consumption
were exclusion criteria. All participants gave their written informed
consent. The experimental protocol was approved by the ethical
committees of the University of Barcelona and Lisbon Medical School
and was performed in accordance with the Declaration of Helsinki.
Prior to the experimental session, subjects completed the State-Trait
Anxiety Inventory (STAI; Spielberger et al., 1988) and all were within a
normal range of state (mean 13 ± 1) and trait (mean 17 ± 1) anxiety
levels. Mean body mass index (BMI) was 22.3 ± 0.8 kg/m2 and all par-
ticipants presented a normal body mass index except one with grade 1
obesity. All except one participant were right-handed. Seven partici-
pants were in the follicular phase, three were in the peri-ovulatory
phase and sixwere in the luteal phase, based on self reportedmenstrual
cycle day. Five subjects were using hormonal contraception, no other
medications were allowed.
Task and procedure
The experimental sessions were conducted in the afternoon, begin-
ning at 2–3 pm. An adapted version of awell-established auditory–visu-
al distraction task (Escera et al., 1998, 2000) was presented with two
different conditions, one featuring a neutral (NEU) and one featuring a
negative emotional content (NEG), as implemented by Domínguez-
Borràs et al (2008). Each condition lasted about 15 min and conditions
were performed 2 h apart (beginning to beginning). The order was
counterbalanced across subjects. Each condition consisted of two
separate blocks of 255 trials with a short interval between them.
Participants sat in a comfortable chair in a dimly lit and electrically
and acoustically shielded room. The task consisted of responding as
fast and accurately as possible whether the two faces on the screen
were equal or different by pressing the correspondent mouse button.
The subjects were instructed to ignore the sounds. In order to reduce
eye blinks and movements during EEG recording, subjects were asked
to blink as little as possible, and to focus on a central ﬁxation cross be-
tween the two pictures. Responses were given through a mouse button
(one mouse button for “the same” and the other button for “different”,
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was the same. Before each experimental condition, subjects performed
practice blocks (composed of 10 trials) using faces with a neutral
expression only and without any auditory stimuli, until they reached a
hit rate (HR) of at least 80%.
In each trial, a task-irrelevant auditory stimulus was presented,
followed after 300 ms (onset-to-onset) by a visual imperative stimulus
(Fig. 1). The total trial length varied from 1200 to 1600 ms (1400ms on
average; jitter +/− 200 ms) and the response window until the end of
the shortest trial was 1200 ms. The auditory sequence consisted of
repetitive standard tones (duration of 200 ms, including fade-in
and fade-out of 10 ms each; 600 Hz; 85 dB; probability of occurrence
p = 80%), occasionally replaced by environmental novel sounds (p =
20%). These novel sounds were selected from a sample of 100 different
specimens (edited to have a duration of 200 ms, including fade-in and
fade-out of 10 ms each; digitally recorded, low-pass ﬁltered at
10,000 Hz; 85 dB), such as those produced by a drill, hammer, rain,
door, telephone ringing, and so forth (Escera et al., 2003). All sounds
were delivered binaurally through headphones (Sennheiser HD 202)
in a randomized order with the only restrictions that the ﬁrst four
stimuli of each block had to be standard tones, that two novel sounds
never appeared consecutively and that each novel sound occurred
only once in each condition. The visual stimuli were pairs of combi-
nations of pictures of faces with either neutral (Fig. 1.A) or fearful
(Fig. 1.B) expression, presented on a computer screen for 400 ms.
We used 12 pictures of faces with either neutral (NEU) or fearful
(NEG) expression from the Ekman and Friesen (1976) database. All
faces had exactly the same probability of occurrence and all had
the same valence (NEU or NEG) in each block. The picture size was
356 × 488 pixels, the vertical angle 9° and the horizontal angle 17°,
accounting for two pictures presented simultaneously with a ﬁxa-
tion cross in between, and the distance from the subjects' eyes to
the screen was 100 cm.
Performance and EEG recording and analysis
Response time (RT) andwhether the button press was correct, wrong
ormissedwere recorded for each trial using Presentation® (Neurobehav-
ioral Systems, Inc). A database was created with the mean response time
for correct responses and hit rate (HR), separately for each condition
(NEU and NEG) and auditory stimulus type (standard and novel).
Distraction by novel sounds was computed as the difference in hit rate
and response time between standard and novel auditory stimuli
(hit rate: NEUstandard trials − NEUnovel trials and NEGstandard
trials− NEGnovel trials; response time: NEUnovel trials− NEUstandard
trials and NEGnovel trials−NEGstandard trials). Performance disruption
due to the processing of negative emotional stimuli was computed asFig. 1. Trial structure. A. Neutral emotional contextthe difference in hit rate and response time between conditions, as ap-
propriate (hit rate: NEUstandard − NEGstandard and NEUnovel −
NEGnovel; response time: NEGstandard − NEUstandard and
NEGnovel − NEUnovel).
EEG activity was continuously recorded, from 64 scalp Ag/AgCl elec-
trodes following the extended 10/10 convention. It was ampliﬁed and
digitalized at a sampling rate of 512 Hz (Eemagine, ANT Software b.v.,
Enschede, Netherlands). The horizontal and vertical electrooculogram
(HEOG and VEOG) were recorded with electrodes placed at the outer
canthus and below the right eye, respectively. An electrode placed on
the tip of the nose was used as the common reference and the ground
was located at the AFz position. Impedances were kept at 5 kΩ or
below during the whole recording session. Recording was performed
with an ANT ampliﬁer of 64 channels (gain 20×; A/D resolution 22
bits, 71.526 nV per bit; ﬁltering 0–138.24 Hz; CMRR N 90 dB).
EEG processing was performed off-line by using Eeprobe 3.1 (ANT
Software BV, Enschede, Netherlands). A digital ﬁnite impulse re-
sponse (FIR) bandpass-ﬁlter from 0.01 to 30 Hz was applied using a
Hamming window. ERPs were averaged for each auditory-stimulus
trial type and emotional condition, for an epoch of 1400ms, compris-
ing a pre-auditory-stimulus baseline of 200 ms. The ﬁrst ﬁve epochs
of each block and epochs following a novel trial were excluded from
averaging. Only epochs corresponding to trials with correct re-
sponses were included in further analyses. Electrooculogram (EOG)
correction was performed by manually selecting a large number of
typical artifacts and accordingly applying a regression algorithm to
compute propagation factors (Eeprobe 3.1, ANT Software BV, En-
schede, the Netherlands). After EOG correction any epochs contain-
ing EEG activity exceeding ±100 μV peak-to-peak amplitudes were
rejected from further analysis. On average, 84% of epochs (252
epochs) with standard sounds and 87% of epochs (87 epochs) with
novel sounds in NEU and 86% of epochs (259 epochs) with standard
sounds and 86% of epochs (86 epochs) with novel sounds in NEG
were retained for averaging.
In the employed paradigm the participants were speciﬁcally
instructed to ignore the distraction stimuli (auditory), hence any related
effects are necessarily involuntary or led by exogenous attention. ERPs
recorded during auditory distraction are typically characterized by an
auditory N1/mismatch negativity (N1/MMN) enhancement, reﬂecting
a detection mechanism leading to attention capture, followed by a
novelty-P3 (nov-P3) reﬂecting the effective orientation of attention
(Escera et al., 1998, 2000). The nov-P3 component has been shown
to be sensitive to the manipulation of the emotional context
(Domínguez-Borràs et al., 2008) and attention (Escera et al., 1998). Sub-
sequently, the re-orienting negativity (RON) reﬂects the re-orientation
of attention back to the task (Schröger and Wolff, 1998). The target
stimuli in the present task were visual, and visual ERPs include the(NEU). B. Negative emotional context (NEG).
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P300 (visP300) reﬂects the conscious processing of the visual stimulus
and is sensitive to attention allocation (Domínguez-Borràs et al., 2008;
Polich, 2007).
To analyze distraction effects, the ERPs elicited to the auditory stim-
uli were considered and difference waveforms (dw) were calculated by
subtracting the ERPs elicited by standards from those elicited by novel
sounds. These difference waveforms revealed an early-onset, long-
lasting positive deﬂection that we assimilated to the novelty-P3. We
measured the auditory P3 (aud-P3) and novelty-P3 (nov-P3) as the
mean amplitude and mean peak latency in the 210–470 ms time win-
dow at F3, Fz, F4, C3, Cz, C4, P3, Pz and P4 electrodes.
To analyze emotional effects, ERP measures in standard trials
were compared. Speciﬁc components were elicited during task-
performance, such as the auditory N1 and P2, visual N1 and P2 and
the cognitive components N2b and visual P300. Since only cognitive
processing was of interest for the present study, the visual P300 (650–
1050 ms at F7, F3, FZ, F4, F8, T7, C3, CZ, C4, T8, P7, P3, PZ, P4 and P8,
350–750 ms from stimulus presentation) was analyzed. Mean ampli-
tudes and mean peak latencies for the considered time window and
electrodes were computed for each deﬂection.Endocrine measurements
Saliva samples were collected by passive drool, using a short straw.
Unstimulated whole saliva was used. For each condition, samples
were collected for DHEA, DHEAS and cortisol measurement before
task (BF), at 30 min (30 min after the beginning of the task, 10 to
15min after the end of the task) and 60min (60min after the beginning
of the task, 40 to 45min after the end of the task). The samples collected
before the ﬁrst condition (i.e. before both the neutral and the negative
condition), were considered as the baseline. Time points to collect the
saliva samples were chosen in accordance to known cortisol raise and
recovery times (raise 10 min after appropriate stimulus, peak at 20–
30 min and recovery at 45–60 min after the end of the stimulus)
(Martins et al., 2001, 2002, 2004; doVale et al., 2011). Furthermore, syn-
chronous 24 h proﬁles were described for DHEA and cortisol and DHEA
half-life is less than 30 min (Rosenfeld et al., 1975). For this reason, the
second condition was started 2 h after the ﬁrst one to allow cortisol and
DHEA levels to recover from the inﬂuence of the ﬁrst condition (return
to a “baseline” level).
Unbound DHEA and cortisol in the peripheral circulation pene-
trate into the saliva via intracellular mechanisms and salivary con-
centrations reﬂect serum concentrations (Ahn et al., 2007; Vining
and McGinley, 1987). DHEAS is not lipid soluble and cannot pene-
trate into the saliva by passive diffusion through cell membranes.
Instead, it squeezes through the tight junctions between salivary
glands. DHEAS concentrations in saliva are therefore dependent on
serum concentration and salivary ﬂow rate (Vining and McGinley,
1987).
Samples were refrigerated at 2–8 °C within 30 min after collection
and were stored at−20 °C within 4 h and until assayed. Each sample
was measured in duplicate using enzyme-linked immunoassays:
salivary DHEA and DHEAS enzyme immunoassay kits (Salimetrics
Europe®, Ltd, Newmarket Suffolk, UK) and high sensitivity salivary
cortisol enzyme immunoassay kits (Salimetrics®, LLC, State College,
PA, USA). DHEA was measured in pg/mL and cortisol was measured
in μg/dL. Due to the inﬂuence of saliva ﬂow rates on DHEAS levels,
the concentration of DHEAS (pg/mL) was multiplied by the ﬂow
rate (mL/min) and the corrected results were obtained as DHEAS mea-
sured per unit of time (pg/min). Theminimal concentrations that can be
distinguished from 0 with the used immunoassays are 5 pg/mL for
DHEA, b0.003 μg/dL for cortisol and b43 pg/mL for DHEAS. Intra- and
interassay coefﬁcients of variation were less than 10% and 15% in
every case, respectively.Statistical analysis
The Statistical Package for the Social Sciences Program (IBM SPSS
Statistics, version 21) was used for data analysis. Results are presented
as the mean ± standard error of the mean (SEM). The normal distribu-
tion of continuous variables was veriﬁed by the Kolmogorov–Smirnov
goodness of ﬁt test.
To explore the effects of the implicit emotional content and auditory
distraction on performance, repeated measures analyses of variance
(ANOVA) were performed on hit rate and response time, including the
within-subjects factors emotional condition (NEU and NEG) and type
of auditory stimulus (standard and novel). Regarding brain responses,
ERPs time-locked to the auditory stimuli were analyzed to explore dis-
traction effects. ERPs time-locked to the visual stimuli (the faces) were
analyzed to explore emotional context effects. To investigate the effects
of the emotional context and auditory distraction on brain responses to
auditory stimuli, repeated measures ANOVAs were carried out on audi-
tory P3 mean amplitude in the timewindow and electrodes considered
above, including the within-subjects factors emotional condition (NEU
and NEG) and type of auditory stimulus (standard and novel). To inves-
tigate the effects of the emotional context on brain responses to visual
stimuli, only standards were included and ANOVAs were performed
on the visual P300mean amplitude in the timewindows and electrodes
considered above, with emotional condition (NEU and NEG) as within-
subjects factor. To investigate the effects of emotional context manipu-
lation on endocrine levels, repeatedmeasures ANOVAswere performed
on DHEA, DHEAS and cortisol levels, including the within-subjects
factors emotional condition (NEU and NEG) and measurement time
(before task, at 30 min and 60 min).
To investigate the endocrine relation to distraction and emotional
context effects at the behavioral level, the previous repeated measures
ANOVAs of behavior parameters were repeated, including baseline
DHEA, DHEAS, cortisol, DHEA/cortisol ratio or DHEAS/DHEA ratio as
covariates. Whenever the endocrine parameters covariated with the
performance or ERP parameters for each type of auditory stimuli or
emotional condition, we performed simple or multiple regression anal-
yses to select the relevant independent endocrine factors and/or to un-
derstand the direction of the relationship. Lastly, as visual P300 peak
latency in both emotional contexts was not directly related, in order
to ﬁnd the relation between visual P300 peak latency and endocrine
parameters, linear and multiple regression analyses were used with
the endocrine parameters as independent variables.
ANOVA results were Greenhouse–Geisser corrected whenever the
assumption of sphericity was violated. The limit of signiﬁcance chosen
wasα=0.05. Post hoc tests were carried out wherever there were sig-
niﬁcant interactions between main factors and the Bonferroni correc-
tion was applied for multiple comparisons. For the endocrine relations
to performance or ERPs the alpha thereforewas set to 0.01 as the effects
were tested for ﬁve variables (cortisol, DHEA, DHEAS, DHEA/cortisol
ratio and DHEAS/DHEA ratio). Effect size estimates of the results were
expressed as eta squared (η2) for ANOVAs and correlation coefﬁcients
(r) for regression analyses.
Results
Performance
Behavioral results for each condition and trial type are presented in
Fig. 2. There was a main effect of emotional context on response time
[F(1,20) = 17.51, p b 0.001, η2 = 0.47], with longer response times
under the emotionally negative context (433 ± 17 ms) than under
the neutral one (379 ± 12 ms). Furthermore, there was a main effect
of trial type on response time [F(1,20) = 31.88, p b 0.001, η2 = 0.61],
with longer response times for novel (423 ± 13 ms) than for standard
(389±14ms) trials, indicating that the novel sounds causeddistraction
of visual task performance (Fig. 2.A). Overall hit rate was 88 ± 1% and
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Fig. 2. Performance results. A. Mean response times for each condition [neutral (NEU) or
negative context (NEG)] and auditory stimulus type (standard or novel). B. Mean hit
rates for each condition and auditory stimulus type. Error bars represent ±1 standard
error of the mean (SEM).
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(Fig. 2.B).
Event-related potentials
Distraction effects
No clear N1-enhancement/MMNnor RONwas elicited and therefore
our analysis focused only on the nov-P3. In fact, the nov-P3 was signif-
icantly elicited as supported by the signiﬁcant differences of the mean
amplitudes in the auditory P3 latency window for standard and novel
trials [F(1,20) = 169.09, p b 0.001, η2 = 0.89;−2.3 ± 0.4 μV in standard
and +1.7 ± 0.5 μV in novel trials], see Fig. 3.A and B. However, there
were no effects of emotional context on the auditory P3 (see Fig. 3.C),
as no signiﬁcant interaction between emotional context and auditory
stimulus type was found.
Emotional context effects
The waveforms elicited by standard trials in the two emotional
contexts are presented in Fig. 3.D. No signiﬁcant emotional effects
were observed on visual P300 as its amplitude was similar in both
conditions. Also, there were no signiﬁcant latency differences in P300,
between emotional conditions.
Endocrine baseline levels and reactivity
Baseline endocrine levels were: DHEA 254 ± 41 pg/mL, DHEAS
5856 ± 690 pg/min and cortisol 764 ± 100 pg/mL, following a normal
distribution. Baseline DHEA level was directly related to baseline
cortisol level (r =+0.63, p = 0.002, n = 21). There was no signiﬁcant
relation between baseline DHEAS and DHEA or DHEAS and cortisol
level. Nevertheless, baseline DHEAS levels were directly related tobaseline DHEA/cortisol ratio (r = +0.56, p = 0.008, n = 21). Baseline
endocrine parameters were not related to age or body mass index and
did not differ according to menstrual cycle phase or between subjects
taking and not taking hormonal contraception.
DHEA, DHEAS and cortisol mean levels for each condition and sam-
ple time are presented in Fig. 4. The repeated measures ANOVA on
DHEA levels revealed a main effect of measurement time on DHEA
levels [F(2,40) = 5.94, p = 0.007, η2 = 0.24; mean levels were 243 ±
42 pg/mL before task, 258 ± 41 pg/mL at 30 min and 309 ± 45 pg/mL
at 60min], see Fig. 4.A and B. There was no signiﬁcant relation between
emotional context and DHEA levels. Moreover, there was no interaction
between DHEAS (Fig. 4.C) or cortisol levels (Fig. 4.D) and the emotional
context or measurement time.
Endocrine relations to performance and event-related potentials
We found no signiﬁcant relations between performance (hit rate
and response times) and endocrine parameters. Regarding event-
related potentials, no signiﬁcant relations were found between endo-
crine parameters and distraction effects. Nevertheless, signiﬁcant rela-
tions were found between endocrine parameters and emotional
context. Higher DHEAS/DHEA ratios before performing the emotionally
negative condition were related to reduced visual P300 amplitudes in
this condition. Thiswas revealed by a signiﬁcant interaction between vi-
sual P300 amplitudes and DHEAS/DHEA ratios [F(1,19) = 9.38, p =
0.006, η2=0.33]with higher DHEAS/DHEA ratios in relation to reduced
visual P300 amplitudes attributed to the negative context (r =−0.58,
p = 0.006, n = 21; see Fig. 5.A). Concerning visual P300 peak latency,
higher DHEA/cortisol (partial r = −0.56, p = 0.003, n = 21) and
DHEAS/DHEA (partial r = −0.60, p = 0.004, n = 21) ratios before
performing the negative emotional context block, were related to
shorter visual P300 peak latencies (Fig. 5.B and C), together explaining
52% of the latency variability. Remarkably, smaller visual P300 ampli-
tudes attributed to the negative context were related to shorter visual
P300 peak latencies (r = +0.53, n = 21, p = 0.015).
Discussion
The present study revealed relations between dehydroepiandroster-
one (DHEA), its sulfated form (DHEAS) and brain processing under an
emotionally negative context induced by images of fearful faces,
suggesting that these neurosteroids may modulate the processing of
emotionally negative information. Although the sounds as well as the
emotional content of the pictures were irrelevant for the task, the
results suggest that the subjects were unable to fully ignore them as
indicated by signiﬁcant effects on performance and brain responses.
The distraction effect of task irrelevant auditory stimuli as well as the
behavioral disruption due to the processing of task irrelevant negative
emotional stimuli have been shown before by other authors (Escera
et al., 1998, 2000; Domínguez-Borràs et al., 2008, 2009; Öhman et al.,
2001), whereas the relation between the neurosteroids and emotional
processing at the brain level is a new ﬁnding.
Novel sounds led to distraction as shown by longer response times
and the elicitation of a signiﬁcant novelty-P3. Conversely, no clear N1-
enhancement/MMN was observed in our results, probably due to a
very early P3 onset, causing an overlap between the components. Re-
cent studies have shown that small deviant stimuli, and hence large
novel sounds, may activate deviance-detection mechanisms as early as
20 ms from sound onset (see Slabu et al., 2010; Escera and Malmierca,
2014) and therefore attention switching may have had occurred
before the supratemporal activation giving rise to the typical N1-
enhancement/MMN trigger response (Yago et al., 2001). Additionally,
in the negative emotional context, response times were longer than in
the neutral context which implicates that the novel sounds effectively
caused distraction and the emotionally negative context effectively
disrupted performance. However, the emotional context did not
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distraction, contrasting with previous studies (Domínguez-Borràs
et al., 2008; Garcia-Garcia et al., 2008) which found an enhancement
of the visual P300 for emotionally negative stimuli (Domínguez-Borràs
et al., 2008). Nevertheless, in studies using faces, some authors have
found visual P300 enhancement by fearful faces (Luo et al., 2010),
while others reported no changes in P300 amplitude (Balconi and
Lucchiari, 2005) as in the present study. Importantly, in the present
study, the emotional content of the imageswas not relevant for the task.
DHEA levels increased after the performance of both conditions, in-
dependent of the emotional context of the task. Interestingly, a previous
study showed that corticotrophin releasing hormone (CRH) levelsincreased with another cognitive task: the visualization of emotionally
signiﬁcantmovies (Martins et al., 2010). In turn, the present results sug-
gest that cognitive tasks are a stimulus for DHEA secretion andmay lead
to a higher DHEA/cortisol ratio. Moreover, it suggests that DHEA is not
just a stress hormone and that some differential regulation of DHEA
and cortisol exists. In fact CRH stimulates corticotrophin secretion and
in turn corticotrophin is a stimulus for cortisol and DHEA secretion
(Nieschlag et al., 1973). This may explain the direct relation we found
between cortisol and DHEA levels.
Boudarene et al. (2002) studied subjects without mental disorders
and varying levels of anxiety, and found that the level of anxietywas re-
lated to the proﬁle of endocrine response after the performance of cog-
nitive tasks: subjects with high anxiety levels in the STAI test had
increased cortisol reactivity and subjects with low anxiety levels
showed an exclusive increase in DHEAS levels. The authors suggested
that the antagonism in DHEAS and cortisol might be related to compe-
tition in their synthesis and its release by the adrenal gland. This agrees
with the results in the present study, in which all the subjects had low
anxiety levels and a DHEA raise but no cortisol response in relation to
the cognitive task (in both emotional conditions), was found. For non-
pathological conditions and low levels of anxiety, this might eventually
represent an adaptive mechanism that includes higher DHEA than
cortisol responses and anti-cortisol effects of DHEA. DHEA increase
however was identical for both emotional contexts, so that DHEA
increase alone is not expected to be related to performance or electro-
physiological effects of the emotional context.
No signiﬁcant relation was found between response times or hit
rates and endocrine measurements. A larger sample may be necessary
to uncover endocrine relations to performance. Nevertheless, an inter-
esting ﬁnding of the present study consists in endocrine relations to
brain responses. A higher DHEA/cortisol ratio was related to lower visu-
al P300 latencies in the negative emotional context, suggesting DHEA to
be protective froman interference of the implicit negative content of the
stimuli with the task which might represent an anti-glucocorticoid ef-
fect of DHEA. In the negative condition, higher DHEAS/DHEA ratios
were also related to lower visual P300 latencies, thus, a higher propor-
tion of DHEA respective to cortisol and a higher proportion of sulfated
to non-sulfated form of DHEA may protect from any interference with
the task caused by the processing of the implicit emotional content of
the stimuli.
In agreement, higher DHEA levels have been previously found to be
related to shorter P300 latencies (Braverman and Blum, 2003;
Braverman et al., 2009). A protective effect of DHEA and DHEAS could
eventually bemediated by anti-cortisol effects and/or neuromodulatory
effects of these hormones. Wang et al. (2013) associated a prolonged
P300 latency with an attentional bias to negative stimuli in high trait
anxiety subjects, who are expected to have higher cortisol levels. On
the contrary, in the present study examining subjects with low trait
anxiety, higher DHEA/cortisol ratios were related to shorter P300 laten-
cies in the negative condition. Higher DHEA/cortisol could be related to
less interferencewith the task caused by the implicit stressful content of
the stimuli, in agreement with the hypothesis of anti-cortisol effects of
DHEA and suggesting a protective mechanism against the deleterious
consequences of stress. The present results also agree with studies at
the cellular level, in which DHEA was protective against the neurotoxic
effects of corticosterone (Balazs et al., 2008).
Lastly, the visual P300 amplitude increments in the negative emo-
tional context as compared to the neutral one, were inversely related
to DHEAS/DHEA ratios, suggesting that the processing of the task-
irrelevant negative content of the stimuli might eventually be reduced
by DHEAS. Even though the participants of the study were healthy
and depression was not screened by any speciﬁc inventory, women in
particular have been shown to be specially sensitive to threatening
stimuli and it has been hypothesized that this might be related to the
higher prevalence of affective disorders in women (Kemp et al., 2004).
Enhanced negative affect is an integral characteristic of depressive
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various procedures, among others by presenting images of faces with
emotional expressions (Dyck et al., 2011; Schneider et al., 1994, 1997).
Although the mechanisms underlying mood persistence in major
depressive disorder remain poorly understood, cognitive theories hy-
pothesize that depressed patients have cognitive biases for emotional
information, which help perpetuate depressive symptoms (Beck,
1967; Gotlib and Joormann, 2010). The present results suggest that
the processing of negative emotional stimuli may be reduced in relation
to higher DHEAS/DHEA levels, which might eventually be involved in
protectivemechanisms against a negative attention bias and undermine
the relation between higher DHEAS levels and lower frequencies of de-
pression, lower depression ratings and better well-being scores previ-
ously described by other authors (Barrett-Connor and Edelstein, 1994;
Barrett-Connor et al., 1999). In line with this hypothesis, subjects with
higher DHEAS/DHEA ratio would process less and have less memory
updating of the implicit negative content of the stimuli and would
thus have a reduced attentional bias towards these stimuli, which
might promotewell-being and contribute to protection fromdepressive
states.
Emotional stimuli usually capture attention more effectively than
non-emotional ones (Öhman et al., 2001) and have an impact on cogni-
tive functions even when they are task-irrelevant (Domínguez-Borràs
et al., 2008). On the other hand, it is hypothesized that protective
mechanisms ﬁlter out irrelevant sensory inputs protecting the higher
brain functions from sensory overload (Braff and Geyer, 1990). Taken
together, our ﬁndings concerning visual P300 latency and visual P300
amplitude under an emotionally negative context showed a relation
between higher DHEA/cortisol and DHEAS/DHEA ratios and less
processing of the negative emotional stimuli and less disruption by
the processing of negative emotional stimuli. These results also suggest
that DHEA and DHEAS potentially play a role or contribute to protective
mechanisms ﬁltering out negative information overload.
A simultaneous relation to latency reduction and decrease in P300
amplitude may seem contradictory at ﬁrst sight, nevertheless, as the
task consisted in deciding whether two faces with the same emotional
expression were equal or different (while the emotional expression
was irrelevant), less processing of the task-irrelevant emotional con-
tent – related to higher DHEAS/DHEA ratios – might be reﬂected in
smaller P300 amplitudes and at the same time shorter P300 latencies
due to a more efﬁcient processing of the task-relevant visual informa-
tion and less interference resulting from the task-irrelevant emotion.
In other words, the P300 amplitude might be reduced as a reﬂection
of less neuronal recruitment due to less allocation of attentional re-
sources to the task-irrelevant emotion, while P300 latencies might be
reduced due to a decreased stimulus evaluation time, likewise due to
less processing of the task-irrelevant emotional content of the images.
This interpretation is consistent with the direct relation we found
between reduced P300 amplitudes and shorter P300 latencies.
Furthermore, it is consistent with previous studies showing that
emotional stimuli elicit an enhanced P300 as compared to neutral
stimuli (Schupp et al., 2004) and longer P300 latencies for negative
emotional target stimuli (Fichtenholtz et al., 2007) as compared to
neutral stimuli. Additionally, emotional stimuli outside the atten-
tional focus have been shown not to elicit an enhanced P300
(MacNamara and Hajcak, 2009).
Endocrine relations to auditory distraction were not found in the
present study: DHEA, DHEAS and cortisol were not related to the
novelty-P3, suggesting that their levels do not modulate auditory dis-
traction processing under an emotionally negative context. This differs
fromour previous ﬁndings concerning auditory distraction underwork-
ingmemory load, inwhichwe found that the novelty-P3 amplitudewas
enhanced in relation to higher baseline cortisol/DHEA ratios (do Vale
et al., 2014). It also suggests that the inﬂuence of the endocrine
parameters on auditory distraction, may depend on the cognitive task
involved.The present results also highlight the relevance of the balance be-
tween DHEA, DHEAS and cortisol concerning the processing of negative
emotions. Importantly, these results agree with ﬁndings at the clinical
level, in which higher DHEAS concentrations and DHEA-to-cortisol ra-
tios but not DHEA levels alone were related to less frequent depression,
less depressive mood and higher well-being scores (Barrett-Connor
et al., 1999; Michael et al., 2000; Young et al., 2002). Although DHEA
and DHEAS can be converted into each other and general common ef-
fects are expected for the sulfated and non-sulfated form of the hor-
mone (Baulieu and Robel, 1998; Dong and Zheng, 2011; Maninger
et al., 2009), several differences exist in their mechanism of action. For
instance, DHEAS has a much more potent excitatory action by NMDA
agonism and gabaminergic antagonism than DHEA, whichmay account
for some differential effects (Baulieu and Robel, 1998; Imamura and
Prasad, 1998;Monnet et al., 1995).Moreover, as stated, sulfated steroids
in general possibly act as endogenous neuromodulators (Gibbs et al.,
2006) and the balance between DHEAS and DHEA might inﬂuence
brain functioning. Previous studies at the cellular and molecular level
showed that DHEAS had neuroprotective effects mediated through
GABA-A receptor antagonism (Majewska, 1992), DHEAS stimulated do-
pamine release from rat hypothalamic cells (Murray and Gillies, 1997)
and DHEAS antagonized the neurotoxic effect of high doses of DHEA
(Gil-ad et al., 2001). These studies suggest potential mechanisms by
which DHEAS could have more potent anti-depressant effects than
DHEA and agree with the present ﬁnding that higher DHEAS/DHEA ra-
tios were related to reduced processing of the negative emotional
content.
In the present study, the participants were in different menstrual
cycle phases and some were using hormonal contraception. This is a
limitation, as DHEA, DHEAS and cortisol levels can change along the
menstrual cycle and with the use of hormonal contraception (Fern
et al., 1978; Wiegratz et al., 2003). Nevertheless, eventually in relation
to the small sample size, in the present study, the endocrine levels
were not signiﬁcantly different according to the menstrual cycle phase
or the use of hormonal contraception. But even considering that
DHEA, DHEAS or cortisol levels could change along the menstrual
cycle or with the use of hormonal contraception, the relations found be-
tween endocrine levels and emotional stimuli processing would not be
invalidated. In any case, given the randomized approach we used
concerning the menstrual cycle phase, the present results are expected
to be independent of the menstrual cycle phase. Finally, the fact that
only female participants were included, limit the outreach of the
present study only to women. DHEAS levels differ between genders,
therefore, another group of participants would be necessary to extend
our conclusions also to men. For further studies, it would be relevant
to study whether the results are identical in men.
Conclusions
In a nutshell, in women, during the processing of stimuli with nega-
tive emotional content, higher DHEA/cortisol and DHEAS/DHEA ratios
were related to shorter visual P300 latencies, suggesting a relation of
these endocrine parameters with shorter stimulus evaluation time and
less interference with the task at hand due to the processing of the
task-irrelevant negative content of the visual stimuli. Additionally,
higher DHEAS/DHEA ratios were related to reduced visual P300 ampli-
tudes suggesting less processing of the negative information, which
might constitute a protective mechanism against negative information
overload.
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